Redeye: Ependion - Overall strong, but a few worrying clouds in the near-term too
Redeye updates its estimates and fair value range after Ependion’s Q2 2023 report, which came in close to our forecasts. Ependion continues to perform well with sales, EBIT, and order intake at all-time highs. However, there is a mixed picture demand-wise for the two business entities and some signals of a weaker industrial cycle, not least in Asia.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/